Aspire-Lakewood Holdings, Inc. (ASBP): Operating Income
-$19.35M
Year ended 2025-12-31
-$7.32M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$19.35M | n/m | 2026-04-08, From 2025-01-01 |
| 2024-12-31 | -$1.21M | n/a | 2026-04-08, From 2024-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | -$19.35M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.22M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$33.21M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$5.12M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$1.04M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$496.3K | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$8.91M | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | -$13.48M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$4.28M | n/m |
Compare ASBP, TCRT, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗